Jakob Adolf

Dr. Jakob Adolf

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 February 2024 in Archives of orthopaedic and trauma surgery
Verified
Journal Article
Closed access
PDF file
JAJakob Adolf
Jakob Adolf
TLT. David Luo
T. David Luo
TGThorsten Gehrke
Thorsten Gehrke
MCMustafa Citak
Mustafa Citak

25 April 2025 in Injury
Verified
Journal Article
Closed access
AHAmir Human Hoveidaei
Amir Human Hoveidaei
SMSeyedArad Mosalamiaghili
SeyedArad Mosalamiaghili
AKAlireza MEHMET ALI AYDINLAR Keshtkar
Alireza MEHMET ALI AYDINLAR Keshtkar
SSSukritJ. Suresh
SukritJ. Suresh
JAJakob Adolf
Jakob Adolf
JCJanet D Conway
Janet D Conway

16 December 2024 in Archives of orthopaedic and trauma surgery
Verified
Journal Article
Closed access
PDF file
AHAmir Human Hoveidaei
Amir Human Hoveidaei
AGAmirhossein Ghaseminejad-Raeini
Amirhossein Ghaseminejad-Raeini
RJRoham Jebeli-Fard
Roham Jebeli-Fard
SHSeyed Hossein Hosseini-Asl
Seyed Hossein Hosseini-Asl
TLTianyi David Luo
Tianyi David Luo
MCMustafa Citak
Mustafa Citak

20 August 2025 in Archives of orthopaedic and trauma surgery
Verified
Journal Article
Closed access
PDF file
SESina Esmaeili
Sina Esmaeili
MPMuhammad Parsa Pashazadeh
Muhammad Parsa Pashazadeh
FNFatemeh Kanaani Nejad
Fatemeh Kanaani Nejad
ASAmirhossein Shirinezhad
Amirhossein Shirinezhad
JAJakob Adolf
Jakob Adolf
JCJanet D Conway
Janet D Conway

14 February 2026 in Antibiotics
Verified
Journal Article
Open access
PDF file
AHAmir Human Hoveidaei
Amir Human Hoveidaei
ARArian Rahimzadeh
Arian Rahimzadeh
SMSara Mohammadi
Sara Mohammadi
PTPranav Thota
Pranav Thota
KVKimia Vakili
Kimia Vakili
JCJanet D Conway
Janet D Conway
Osteomyelitis (OM), an inflammatory condition of the bone tissue, is a complex orthopedic condition marked by chronic inflammation, diagnostic uncertainty, and recurrent infections. Despite standard treatments—including surgical debridement, antimicrobial therapy, and bone reconstruction—many patients continue to experience recurrence and treatment failure. Growing molecular evidence indicates that host genetic factors play a crucial role in shaping immune responses and influencing disease progression in OM. This narrative review synthesizes current knowledge from candidate gene single-nucleotide polymorphism (SNP) association studies to illustrate how specific genetic variations contribute to OM pathogenesis, diagnostic refinement, and treatment outcomes. We examined key immunogenetic variants within genes involved in inflammatory signaling, pathogen recognition, and neutrophil regulation. Our synthesis identifies a landscape of pro-inflammatory SNPs, such as IL-1β rs16944 and NLRP3 rs10754558, that are associated with increased susceptibility to chronic or post-traumatic OM, as well as SNPs that are associated with protective effects that may favor infection resolution, such as within the NOS2 and VDR genes. These SNP-driven differences in inflammasome activity, cytokine pathways, and oxidative stress responses highlight emerging opportunities for individualized therapeutic strategies. This review consolidates these variants, providing a genetic framework to analyze host susceptibility and differentiating high risk from protective genetic profiles. Integrating genomic insights into OM management represents a promising shift toward personalized medicine, enhancing diagnostic precision, informing targeted interventions, and improving prognostic assessment. Continued large-scale validation of candidate SNPs and translational genomic models will be essential to support their future clinical application.

Verified
Journal Article
Open access
PDF file
DTDimitar Tenev
Dimitar Tenev
BHBenedikt Jasper Hochbein
Benedikt Jasper Hochbein
GEGeorgi Enev
Georgi Enev
NCNikolay Cherkezov
Nikolay Cherkezov
JAJakob Adolf
Jakob Adolf
NDNikolay Dimitrov
Nikolay Dimitrov
Kienböck disease, osteonecrosis of the lunate of uncertain aetiology, presents with progressive pain, stiffness, and grip loss in dominant-hand-using adults during their most productive working years, yet its rehabilitation literature has lagged behind its surgical counterpart. This narrative review synthesises current rehabilitation evidence across conservative and post-operative pathways, mapping recommendations to disease stage and to surgical procedure. Following SANRA-aligned methods with selected PRISMA 2020 transparency elements, we appraise immobilisation and orthotic management, dart-throwing-motion-plane mobilisation, sensorimotor retraining, oedema and pain control, psychosocial screening, and procedure-specific protocols that span joint-levelling osteotomy, vascularised bone grafting (including medial femoral trochlea flap), limited intercarpal arthrodeses, proximal row carpectomy, wrist denervation, and salvage arthrodesis or arthroplasty. Patient-reported, performance-based, and occupational outcome instruments are reviewed, with explicit declaration that no Kienböck-validated MCIDs exist. We also set out an integrative reference frame that cross-walks osseous, articular, and tissue-healing axes, offered as clinical orientation rather than as a validated algorithm. The most pressing evidence gaps (Kienböck-specific functional movement screens, sustained return-to-work data, and procedure-specific rehabilitation cohorts) are translated into four registered, powered, COMET-aligned trial proposals.